Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Dowling Stough

Dermatology Hot Springs, AR Medical Doctor

NPI 1831199884 CMS profile 309954

3633 Central Ave, Ste N, Hot Springs, AR 71913

Open in the dashboard

General payments

$1,546

79 records reported · program years 2019–2025

Research payments

$242,137

Paid to them · 3 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$3,545,933 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Dowling Stough of Hot Springs, AR is reported in the CMS Open Payments database as having received $1,546 across 79 general payments and $242,137 in research payments paid to them. Separately, studies naming them as principal investigator received $3,545,933 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 96th percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $220 9
2025 Research $56,168 1
2024 General $222 12
2024 Research $182,769 1
2023 General $184 10
2022 General $149 9
2021 General $47 3
2020 General $149 4
2019 General $575 32
2019 Research $3,200 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Dowling Stough
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Dowling Stough were reported at $220. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Dowling Stough Dermatology median Middle half National median
2019 $575 $454 $129–$1,240 $163
2020 $149 $235 $81–$756 $114
2021 $47 $377 $108–$1,108 $132
2022 $149 $514 $143–$1,391 $149
2023 $184 $607 $159–$1,674 $160
2024 $222 $751 $204–$1,903 $164
2025 $220 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $374 22 payments
  2. Novartis Pharmaceuticals Corporation $193 12 payments
  3. Janssen Biotech, Inc. $187 3 payments
  4. Genzyme Corporation $185 6 payments
  5. Sun Pharmaceutical Industries Inc. $156 9 payments
  6. Amgen Inc. $127 7 payments
  7. Lilly USA, LLC $90 6 payments
  8. LEO Pharma Inc. $50 2 payments
  9. Kerecis Limited $31 2 payments
  10. Genentech USA, Inc. $29 2 payments
  11. Other $125 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $1,320 75 payments
  2. Education $226 4 payments
Products named General payments · program years 2019–2025
  1. SKYRIZI $226 13 payments
  2. TREMFYA $187 3 payments
  3. HUMIRA $168 10 payments
  4. COSENTYX $132 8 payments
  5. Enbrel $113 6 payments
  6. DUPIXENT $111 5 payments
  7. ILUMYA $93 5 payments
  8. TALTZ $90 6 payments
  9. BLU-U $46 3 payments
  10. Odomzo $46 3 payments
  11. Other $415 27 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Nielsen BioSciences, Inc. $238,937 2 payments
  2. Bausch Health US, LLC $3,200 1 payment

Records

82 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in Arkansas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record